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survey was developed for patients (adults/children) and caregivers. Patients were 
recruited by patient organisations in cystic fibrosis (CF), Prader–Willi syndrome 
(PWS), haemophilia (HEMO), Duchenne muscular dystrophy (DMD), epidermolysis 
bullosa (EB), fragile X syndrome (FXS), scleroderma (SCL), mucopolysaccharidosis 
(MPS), juvenile idiopathic arthritis (JIA) and histiocytosis (HIS). Demography amd 
main characteristics were recorded. Patients’ and caregivers’ health state was 
assessed by the EQ-5D-5L, disability and caregivers’ burden by the Barthel Index 
and Zarit Burden Interview questionnaires. Results: In Hungary, 296 Hungarian 
patients (children: 161, 54%) participated in the study (CF 110, PWS 5, HEMO 58, 
DMD 57, EB 6, FXS 12, SCL 38 and MPS 10 patients), no data were obtained in JIA and 
HIS. Mean age among adults/children was 37.0 (SD 16.1) / 9.6 (SD= 4.5) years, and 
disease duration was 18.5 (SD= 14.4) / 7.1 (SD= 4.5) years, respectively. The lowest 
average EQ-5D-5L score was found in MPS (0.134 / 0.070) and DMD (0.310 / 0.198) 
just alike with the Barthel Index (MPS: 35.6; DMD 58.0). Caregivers’ (N= 95) mean 
age was 39.2 (SD= 8.0) years and their EQ-5D-5L score (0.797, SD= 0.251) was not sig-
nificantly different from the general populations’ average. Satisfaction with health 
care (1-10 Likert scale) was the lowest in MPS, DMD and EB (mean 4.1, 5.2 and 
4.3). ConClusions: Rare diseases induce substantial deterioration of patients’ 
quality of life and impose burden on caregivers. Taking an integrated approach our 
results can serve for international comparisons and facilitate further investigations 
in other orphan diseases.
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objeCtives: The aim of the UK multi-centre LupusQoL Sensitivity Study is to 
assess whether the LupusQoL, a systemic lupus erythematosus (SLE) specific, 
health-related quality of life measure is sensitive to change when disease activ-
ity improves or deteriorates. Methods: Patients with SLE experiencing a flare 
(baseline) & requiring an increase in treatment were recruited. Assessments were 
undertaken at baseline & monthly for 9 months & included BILAG-2004 disease 
activity index & the LupusQoL with 8 domains and scores ranging from 0 (worst) 
to 100 (best HRQoL). LupusQoL domain scores when disease activity improved or 
deteriorated between consecutive time-points are reported as mean changes, with 
95% CI constructed using robust standard errors to account for repeated patient 
assessments. Results: Mean (SD) age was 40.9 (12.8) & duration since diagno-
sis was 9.3 (8.1) years for the 101 patients recruited; 94% females, 62.6% white 
Caucasians. At baseline all mean LupusQoL domain scores were < 52. Scores for 
LupusQoL physical health (+4.0, 95%CI 1.9 to 6.1), pain (+7.7, 95%CI 4.8 to 10.5) & 
fatigue (+4.1, 95%CI 1.7 to 6.5) increased when BILAG improved. Scores for physi-
cal health (-4.9, 95% -9.4 to -0.4) and pain (-6.9, 95%CI -12.9 to -0.8) decreased with 
a major BILAG deterioration but changes with a minor deterioration were small 
and non-significant. The effects of improvements & deterioration in BILAG on 
the other LupusQoL domain scores were smaller. ConClusions: Improvement 
and deterioration of LupusQoL domain scores for physical health, pain & fatigue 
domain scores was seen in patients with significant changes in disease activity 
over 1 month. Sensitivity to change of other LupusQoL domains in relation to 
changes in disease activity may need to be evaluated over a longer interval as the 
more emotive type of response to the disease & its consequences may be latent 
and therefore not evident at monthly intervals.
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objeCtives: To assess the Quality of Life (QoL), focusing on level of pain, of patients 
submitted to surgical interventions with robotic technique in comparison with 
traditional approach in the Italian setting. Methods: The prospective multicen-
tre study analysed the QoL of 699 patients submitted to surgical interventions, 
enrolled in 8 Italian Hospitals for the period February 2011-May 2014. The specialties 
were general, thoracic, gynecological surgery performed with open, manual lapa-
roscopic or robotic technique. Patients completed two questionnaires: one related 
to pain intensity during the hospitalization and one fulfilled at home related to 
pain intensity and its impact on daily activities, mood, relationship, sleep. Pain was 
measured using the scale of facial expressions corresponding to the Visual Analog 
Scale. For each intervention and specialty, linear regression for repeated measure, 
corrected by length of stay and use of analgesics, were performed to explain level 
of pain during hospitalization and at home, respectively. Results: Level of pain 
during hospitalization is significantly (p= 0.05) lower in general and gynecological 
robotic surgery versus the open technique, but not versus laparoscopic, while robotic 
thoracic surgery presents significant differences with laparoscopic but not with 
open surgery (p= 0.059). Level of pain at home is significantly different for robotic 
interventions versus open both in general and gynecological surgery; moreover, 
with respect to laparoscopic interventions, the differences are significant both in 
gynecological and in thoracic but not in general surgery. ConClusions: The study 
gives us insightful knowledge about QoL, focusing on pain, of patients submitted to 
surgical interventions with robotic technique vs traditional surgery. Further analysis 
are in progress to combine results on QoL, not only referred to level of pain, with 
clinical severity and other indicators of clinical efficacy as length of stay, operating 
hemophilic joint health (0.67vs. 0.73, p< .001) or disability (0.65 vs. 0.70, p< .001) as 
similar as in the results of Haemo-QoL. With patients who were either on a job or 
students (n= 467, 77.2%), LPT was estimated at 127.81 hours per month on average. 
Of 467, patients with inhibitor or disability showed higher LPT compared to those 
without inhibitor (130.61 vs. 126.61 hours per month, p= 0.486) or disability. (132.27 
vs. 124.95 hours per month p=.087). ConClusions: The study findings suggest that 
patients’ clinical characteristics should take into account for the management of 
hemophilia given patient-reported outcomes differed by clinical manifestations.
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objeCtives: To assess the burden of LN in comparison to SLE patients without 
Nephritis (Non-LN) in routine clinical practices in EU. Methods: A multi-center 
medical chart-review of adult (16-89yrs) SLE patients was conducted among rheu-
matologists and internal medicine physicians in UK/France/Germany/Italy/Spain 
(5EU). Physicians were recruited from a geographically representative sample in 
each country. Approx. 5 consecutive eligible persistent active or relapse remitting 
SLE patients currently managed as part of usual care were identified. Physicians 
abstracted de-identified patient data on disease characteristics, lab values and 
treatment patterns. LN and Non-LN cohorts were compared using descriptive 
statistics. Results: 168 LN patients and 569 non-LN patients with SLE were ana-
lyzed. Patient characteristics included (LN/Non-LN): age (yrs): 40.2/42.7; % Female: 
82.7/79.4; % Caucasian: 82.7%/88.8%; % full-time employment: 32.1/36.0; % part-time 
employment: 19.0%/22.0%. Among LN/Non-LN cohorts, frequency of clinic visits was: 
9.5wks/10.6wks, % currently receiving care in in-patient setting was: 14.9/8.8, % hos-
pitalized > = 1 in the past-year was: 49.4/29.7; mean # of organ manifestations was: 
3.9/3.0. Top-5 organ manifestations were (% LN/Non-LN): musculoskeletal: 85.1/90.8, 
mucocutaneous: 85.1/84.8, haematologic: 51.8/52.2, renal: 100.0/5.9, pulmonary: 
16.7/16.2; % experiencing a flare was (LN/Non-LN): 23.2/16.6. Renal biopsy was per-
formed in 87.5% (LN) and 4.0% (Non-LN) of patients. Steroids were used by 82.1% 
(LN) and 69.4% (Non-LN). % patients with low C3 and C4 was LN: 66.3/48.1/Non-LN: 
60.2/50.0; mean ESR scores were 40.2 (LN) and 36.8 (Non-LN). Among patients with 
available data, SELENA-SLEDAI scores were 11.5 (LN) and 8.5 (Non-LN). Humanistic 
burden (reported via physician ratings, on a scale of 0 (most impact) to 7 (least impact)) 
was (LN/Non-LN, mean scores): ability to perform every-day tasks: 5.0/5.3, ability to 
interact fully with family and friends: 5.4/5.6, and ability to work/keep employment: 
4.5/5.0. ConClusions: LN cohorts had higher clinical and humanistic burden in 5EU 
in comparison to their non-LN SLE counterparts. Factors influencing the observed 
burden, including the therapeutic strategies used in these geographies warrant fur-
ther investigation to manage SLE, and LN in particular, optimally.
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objeCtives: To qualitatively assess the impact of Psoriasis on patient 
QoL. Methods: An ethnographic study with moderate/severe Psoriasis patients 
was conducted in 4EU (UK/France/Spain/Italy) and the US to explore patients’ views 
on treatment options and Psoriasis impact on QoL. Anthropologists and ethnog-
raphers spent several-hours with consented patients and filmed their behaviours 
inside and outside their homes in everyday situations. 175 hours of recordings/notes 
were analysed to identify QoL-related themes: self-image, psychological effects of 
psoriasis (e. g., anxiety/depression), life-style changes due to Psoriasis, relationship 
with family, friends and colleagues. Results: Study included 35 adult patients (4EU: 
20, US: 15; mean age: 39 yrs; female: 65%). Patients described their appearance with 
a sense of disgust and self-loathing. Feelings of frustration were often expressed due 
to a perceived lack of control of their lives. Prior to biologic initiation, daily rituals 
absorbed good part of their day, including waking up earlier to apply creams, going 
to work earlier to check their appearance and cover patches of dead skin. Due to 
lack of cultural discourse and patient’s difficulty in articulating Psoriasis’ impact, 
partners and family did not know how to react nor did they realize the full extent 
of the problem. Difficulty in getting appropriate psychological support needed left 
them with a feeling of resignation. As a result, majority dealt with their issues in 
isolation. Most patients experienced social discriminations due to Psoriasis which 
led some to lie about their disease, keeping it a secret. Biologic experienced patients 
noticed a significant improvement physically, but psychological scarring remained. 
Despite their regained confidence owing to the effectiveness of biologics, they still 
did not discuss their condition with family and friends. ConClusions: Patients 
with Psoriasis experienced significantly lower quality of life and high psychological 
scarring. Ethnographic study design vividly depicted the unarticulated and emo-
tional impact of Psoriasis on patients’ everyday lives.
PSY94
heaLth reLateD quaLItY of LIfe of PatIentS anD theIr caregIverS In 
rare DISeaSeS reSuLtS of the burqoL-rD Project In hungarY
Péntek M.1, Baji P.1, Pogány G.2, Brodszky V.1, Boncz I.3, Gulácsi L.1
1Corvinus University of Budapest, Budapest, Hungary, 2Hungarian Federation of People with Rare 
and Congenital Diseases, Budapest, Hungary, 3Faculty of Health Sciences, University of Pécs, Pécs, 
Hungary
objeCtives: The Social Economic Burden and Health-Related Quality of Life in 
Patients with Rare Diseases in Europe (BURQOL-RD, http://www.burqol-rd.com/) 
project aimed to investigate disease burden and self-percieved health outcomes of 
patients and their caregivers in rare diseases in eight EU countries (Bulgaria, France, 
Germany, Hungary, Italy, Sweden, Spain, UK). Methods: An online questionnaire 
